CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 6,926 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00182949
NCT00182949N/ACompleted

Genetics and Epidemiology of Aging Associated Conditions in the Sardinian Population (SARDINIA)

National Institute on Aging (NIA)·observational·Posted Sep 16, 2005·Updated Apr 5, 2018

In Brief

An observational study for Heart Disease and 2 related conditions. Completed, enrolled 6,926 participants across 1 site.

Detailed Summary

Background: \- The island of Sardinia, an Italian region, has a population that is highly interrelated. Researchers have developed the SardiNIA longitudinal study to examine the possible genetic factors that predispose individuals to diseases and to various inherited conditions. In the study, participants will be drawn from four towns in the Ogliastra region (Lanusei, Ilbono, Elini, and Arzana), and their DNA will be analyzed and compared with a long-term assessment of various health-related events. The SardiNIA study is designed to improve understanding of the genetic factors involved in age-associated diseases and disorders, and provide possible points of intervention that may help prevent diseases. Objectives: \- To conduct a long-term study of genetics and epidemiology in a small and highly interrelated population. Eligibility: \- Individuals at least 18 years of age (at least 14 years of age for Phase 1 of the study) who live in the province of Ogliastra in eastern Sardinia. Design: * This 10-year study will involve three phases: collecting initial blood samples and medical history (years 1 to 4), and two sets of follow-up visits to collect additional data (3 years apart). * Participants will provide detailed medical history and information for long-term study, primarily involving the following aspects: * Demographic/family and clinical variables (e.g., medications, fertility, hospitalizations and surgical procedures, age of relatives who are still alive, age and cause of death in deceased relatives) (Phase 1) * Complete physical examination, including measures of height and weight, blood pressure, and basic heart function (Phase 1) * Blood and urine samples (Phase 1) * Heart and lung function tests (Phase 1) * Assessment of general personality traits and possible history of depression (Phase 1) * Dietary assessment through a food frequency questionnaire (Phase 1) * Cognitive tests of attention, memory, and concentration (Phases 1 and 2) * Frailty-related tests (e.g., hand grip strength, walking speed, bone strength) (Phases 1 and 2) * Eye examination to test for evidence of disease or macular degeneration (Phases 1 and 2) * Kidney and thyroid ultrasound (Phases 1, 2, and 3)

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly
Collaborators--

Timeline

N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 16, 2005
Enrollment StartNov 19, 2003
Study CompletionJan 2, 2015
TodayJul 2, 2026
Posted 20.8 years ago